Inicio>>Signaling Pathways>> Others>> UDP Glucuronosyltransferases>>Propofol β-D-Glucuronide

Propofol β-D-Glucuronide

Catalog No.GC18569

Propofol β-D-glucuronide is a metabolite of propofol sulfate , a short-acting anesthetic agent.

Products are for research use only. Not for human use. We do not sell to patients.

Propofol β-D-Glucuronide Chemical Structure

Cas No.: 114991-26-3

Tamaño Precio Disponibilidad Cantidad
500μg
44,00 $
Disponible
1mg
79,00 $
Disponible
5mg
294,00 $
Disponible
10mg
558,00 $
Disponible

Tel:(909) 407-4943 Email: sales@glpbio.com


Reseñas de cliente

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Product has been cited by 1 publications

Description Chemical Properties Product Documents Related Products

Propofol β-D-glucuronide is a metabolite of propofol sulfate , a short-acting anesthetic agent. [1] [2] The metabolite is generated through the glucuronidation of propofol by uridine diphosphate glucuronosyltransferases. Propofol metabolism appears to occur more rapidly in women than men. [1]

Reference:
[1]. Choong, E., Loryan, I., Lindqvist, M., et al. Sex difference in formation of propofol metabolites: A replication stud. Basic Clin.Pharmacol.Toxicol. 113(2), 126-131 (2013).
[2]. Sørensen, L.K., and Hasselstrøm, J.B. Simultaneous determination of propofol and its glucuronide in whole blood by liquid chromatography-electrospray tandem mass spectrometry and the influence of sample storage conditions on the reliability of the test results. J.Pharm.Biomed.Anal. 109, (2015).

Reseñas

Review for Propofol β-D-Glucuronide

Average Rating: 5 ★★★★★ (Based on Reviews and 18 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Propofol β-D-Glucuronide

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.